Stantec Inc (STN) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has a history of growth in revenue, the recent financial performance shows a decline in net income, EPS, and gross margin. Additionally, technical indicators and trading signals do not present a compelling entry point. Analysts remain positive with raised price targets, but the lack of significant positive catalysts and neutral sentiment from hedge funds and insiders suggest holding off on immediate investment.
The MACD is above 0 but positively contracting, indicating weakening bullish momentum. RSI is neutral at 47.21, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 89.332, with resistance at 91.994 and support at 86.669.

Analyst ratings remain positive with raised price targets. The stock has a 2.29% chance of increasing in the next week.
Recent financial performance shows a decline in net income (-4.18% YoY), EPS (-4.65% YoY), and gross margin (-3.82% YoY). No significant hedge fund or insider trading trends. No recent news or congress trading data.
In Q4 2025, revenue increased by 10.91% YoY to 1.64 billion, but net income dropped by 4.18% YoY to 93.9 million. EPS also declined by 4.65% YoY to 0.82, and gross margin decreased by 3.82% YoY to 48.14.
Analysts are generally positive with raised price targets. Stifel raised its price target to C$160, CIBC to C$173, and RBC Capital to C$175, all maintaining buy or outperform ratings. However, Scotiabank lowered its target to C$146 while maintaining an outperform rating.